OUE Healthcare Limited 1H2025 Financial Results: Analysis and Outlook

OUE Healthcare Limited has released its unaudited interim financial statements for the half year ended 30 June 2025. The financial results reflect a period of operational resilience, ongoing strategic adjustments, and exposure to currency fluctuations and sector-specific challenges. Below, we break down the key financial metrics, year-over-year (YoY) comparisons, and highlight exceptional items and material business events.

Key Financial Metrics & Performance Table

Historical Performance & Notable Trends

• Revenue: Revenue remained stable, increasing marginally by 0.3% YoY, mainly driven by higher contributions from the O2 Group and the Wuxi hospital, partially offset by currency weakness and the closure of the pharmaceutical distribution business in China.
• Profitability: Profit before tax grew robustly by 15% YoY, and net profit after tax rose by 26%, reflecting improved operational efficiency and lower tax expense. However, profit attributable to owners remained negative, though losses narrowed.
• Gross Profit: Marginally decreased, reflecting softer performance in some asset segments.
• EPS: Remained negative, but improved significantly YoY (loss per share narrowed).
• Net Asset Value: Declined from 6.38 cents (FY2024) to 5.98 cents per share, mainly due to currency translation losses and distributions to non-controlling interests.

Exceptional Earnings & Expenses

• Fair Value Gains: The Group recorded net fair value gains of \$2.63m on First REIT’s investment properties in 1H2025, versus losses of \$6.27m in 1H2024.
• Foreign Exchange Losses: Notable FX losses (\$4.02m) were incurred in the current period, reflecting the impact of a weaker Indonesian Rupiah and Japanese Yen.
• Other Income: Included proceeds from litigation-related proceedings and government grants.

Dividends

No interim or final dividends were declared or paid for 1H2025 or 1H2024. The company noted cash flow and working capital requirements as the reason for not paying dividends.

Legal Disputes and Provisions

• Litigation: The company remains involved in several legacy legal disputes, notably with David Lin (enforcement of arbitration awards in multiple jurisdictions) and Fan Kow Hin (bankruptcy proceedings and recovery of indemnified amounts).
• Provisions: The Group retained a \$20.14m legal provision, with minor utilization for legal costs during the period.

Related-Party Transactions & Fund Flows

• Significant related-party loans continue, including interest-free loans extended by the immediate holding company and its subsidiaries.
• Ongoing secondment agreements with ITOCHU entities for management personnel, with payments expected to total \$344,000 in FY2025.

Business Events and Corporate Actions

• No share buybacks, new placements, or treasury shares. No outstanding convertibles as of 30 June 2025.
• First REIT (a major subsidiary) issued new units, diluting OUE Healthcare’s stake from 32.4% to 32.2%.
• No major asset sales or acquisitions during the reporting period. The group continues asset-light expansion through partnerships and management contracts.
• Debt refinancing is in progress, with significant tranches of borrowings due in the next 12 months—management is confident of refinancing these facilities.

Macroeconomic and Sector Outlook

• Global economic conditions remain challenging, with headwinds from geopolitical tensions, trade barriers, and currency volatility.
• The Asian healthcare sector is resilient, supported by demographics (ageing population), rising affluence, and government spending.
• The Group’s operations in Singapore, China, and Myanmar continue to expand, with new service offerings in Singapore and the expected opening of a flagship hospital in Shenzhen, China, in 2025.
• Risks include ongoing legal disputes and the need to refinance short-term borrowings.

Chairman’s Statement

“The global economy is facing substantial headwinds, with ongoing geopolitical tensions, increased trade barriers and heightened policy uncertainty… Amidst this broader economic context, the healthcare sector in Asia has continued to demonstrate resilience and stability. This is driven by several key themes, especially a rapidly ageing population across the region as well as the growing health awareness among the populace, coupled with rising affluence. These factors collectively bolster the sustained need for high-quality healthcare services. Through these volatilities, the Group is committed to sustainable growth by focusing on our three-pronged approach of fostering strategic partnerships, maintaining an asset-light business, and continuing our pan-Asian expansion. These initiatives enable us to strengthen our vision of being the trusted healthcare provider of choice in the communities we serve.”

The tone is constructive and cautiously optimistic, with an emphasis on resilience, sector stability, and ongoing growth initiatives despite macroeconomic uncertainty.

Conclusion & Investment Recommendations

Overall Assessment: OUE Healthcare Limited’s financial performance for 1H2025 demonstrates resilience and operational improvement, with higher profits and narrowed losses attributable to owners. The company benefits from sectoral tailwinds but continues to face currency, legal, and refinancing risks.

If You Are Currently Holding the Stock:

• Maintain a hold position. The company is showing improving profitability and solid sector positioning. Monitor progress on debt refinancing and legal case outcomes, as well as any signs of dividend resumption or further improvement in core earnings attributable to owners.

If You Are Not Currently Holding the Stock:

• Adopt a wait-and-see approach. While the sector is attractive and the company has improved operationally, the absence of dividends, ongoing legal risks, and negative EPS for shareholders mean a clear catalyst is needed before considering entry. Watch for evidence of sustainable net profits to shareholders, successful refinancing, and/or strategic expansion bearing fruit.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own due diligence and consider their individual financial situation and risk tolerance before making investment decisions. Past performance is not indicative of future results.

View OUE Healthcare Historical chart here